Aviridi names real estate veteran Jeffrey Rutishauser as

PHILADELPHIA, July 28. 2022 (GLOBE NEWSWIRE) — The Philadelphia Life Sciences Corridor is one of the top 10 life science research talent hubs in the United States, according to a CBRE reportbut needs a development space that can keep pace with innovation. Aviridia life science company and a qualified opportunity zone company, is committed to meeting this growing demand.

The company announced the addition of real estate development veteran Jeffrey Rutishauser as a strategic advisor and the acquisition of an 11-acre parcel of industrial land in Pottstown, Pennsylvania to develop a manufacturing plant.

Rutishauser has over 30 years of experience in commercial real estate development across the Americas and Europe, served as managing director of Amstar Global Partners Ltd., and managing director and co-director of AIG/Lincoln, a multi-billion dollar developer.

“Jeff brings a rich set of experiences to Aviridi, including in-depth knowledge of the development process, project finance and capital markets,” said Jamie Anderson, Co-Founder of Aviridi. “His experience with large-scale development projects is unparalleled and will help us continue to build Philadelphia’s growing life sciences corridor.”

According to a CBRE Life Sciences Trends Reportbiotech research and development jobs are growing at their fastest pace on record, but available lab space is limited, with demand in Q3 2021 up nearly 40% from Q1 in the Philadelphia area.

“As we’ve seen through several economic cycles, real estate adapts to changing end-user needs,” Rutishauser said. “Life sciences real estate is entering an opportunistic phase where new technologies require flexible and cost-effective laboratory and manufacturing space so that the next wave of leading biotech companies can succeed.”

Aviridi intends to prepare the 11-acre site for redevelopment as an Opportunity Zone facility and position the site with a life sciences anchor tenant before initiating new construction. Aviridi believes that investments in advanced biofermentation – the manufacturing process of biosynthesis combined with fermentation – are key to creating a sustainable future and better products.

Learn more about biofermentation and how life sciences can help create a sustainable future.

About Aviridi
Aviridi is a life sciences platform and skilled opportunity area company that enables more effective, sustainable, and consistently high quality ingredients for pharmaceuticals, nutraceuticals, and consumer products. Through its life science R&D and biofermentation capability, Aviridi aims to ease pressure on global supply chains and meet consumer demand while creating a more sustainable world. Learn more about Aviridi.co.

Media Contact
Charity Lacey
Gregory FCA
Office: 929.561.5991
[email protected]

Company details
[email protected]

Comments are closed.